(Q24240130)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821308%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

review article

1 reference

title

Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821308%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

1 reference

sensorineural hearing loss

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821308%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Lekha Agarwal

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821308%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

7 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821308%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821308%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821308%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

CD003422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821308%20AND%20SRC:MED&resulttype=core&format=json

Effect of prostaglandin E1 on idiopathic sudden sensorineural hearing loss: a double-blinded clinical study

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Therapeutic effect of lipoprostaglandin E1 on sudden hearing loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Lipo-prostaglandin E1 in combination with steroid therapy is effective for treatment of sudden sensorineural hearing loss in Korean patients with Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Management of sudden deafness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Prospective randomized study on the comparative effect between 10% HES 200/0.5 and 6% HES 200/0.5 in patients with hearing loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

[Ginkgo extract EGb 761 (tenobin)/HAES versus naftidrofuryl (Dusodril)/HAES. A randomized study of therapy of sudden deafness].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Sudden deafness: a comparison of anticoagulant therapy and carbogen inhalation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Effect of single-drug treatment on idiopathic sudden sensorineural hearing loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Vasoactive therapy versus placebo in the treatment of sudden hearing loss: a double-blind clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

[Treatment of sudden deafness with the calcium antagonist nimodipine. Results of a comparative study]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Calcium antagonists in the treatment of sudden deafness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Evaluation of prostaglandin E1 therapy for sudden deafness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Ginkgo biloba extract EGb 761 or pentoxifylline for the treatment of sudden deafness: a randomized, reference-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Treatment of sudden deafness: carbon dioxide and oxygen inhalation and steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

A cohort study of summary reports of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Steroids for idiopathic sudden sensorineural hearing loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Measurement of Oxygen Tension in Human Perilymph

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003422.PUB4

Treatment of vascular inner ear disease in vascular patients with pentoxifylline: a controlled, randomized trial.

21 January 2018

1 reference

12 December 2020

Sudden hypoacusis treated with hyperbaric oxygen therapy: a controlled study.

1 reference

12 December 2020

Sudden sensorineural hearing loss

1 reference

12 December 2020

Sudden hearing loss: an update.

1 reference

12 December 2020

Idiopathic sudden sensorineural hearing loss

1 reference

12 December 2020

Medical management of sudden hearing loss

1 reference

12 December 2020

(Treatment of sudden deafness: first results of a comparative study).

1 reference

12 December 2020

[Therapy of sudden deafness--naftidrofuryl (Dusodril) and pentoxifylline (Trental) compared]

1 reference

12 December 2020

Sodium enoxaparin and venovenous hemofiltration in treating sudden sensorineural hearing loss and tinnitus.

1 reference

12 December 2020

Therapy of sudden deafness with O2/CO2 inhalation (author's transl)

1 reference

12 December 2020

[Randomized double-blind study of therapy of sudden deafness. Low molecular weight dextran + naftidrofuryl vs. low molecular weight dextran + placebo].

1 reference

12 December 2020

Sudden sensorineural hearing loss

1 reference

12 December 2020

Sudden sensorineural hearing loss influence of hemodynamical and hemorheological factors on spontaneous recovery and therapy results.

1 reference

12 December 2020

[Therapeutic trial in acute cochlear deafness. A comparative study of Ginkgo biloba extract and nicergoline].

1 reference

12 December 2020

[Sudden deafness--on the age dependence of therapy results with reference to naftidrofuryl (Dusodril)]

1 reference

12 December 2020

The etiology of idiopathic sudden sensorineural hearing loss. A review of the literature.

1 reference

12 December 2020

[Carbogen combined with drugs in the treatment of sudden deafness]

1 reference

12 December 2020

Sudden sensorineural hearing loss: etiologies and treatments.

1 reference

12 December 2020

10.1002/14651858.CD003422.PUB4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19821308%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

1 reference